Jcarl Barrett, Chief Scientific Officer

Professional Overview

Jcarl Barrett is a highly accomplished biomedical research leader with over two decades of experience in the pharmaceutical and academic sectors. As the Chief Scientific Officer at Precede Biosciences, he is responsible for driving the company's scientific strategy, overseeing translational research, and leveraging his deep expertise in oncology and biomarker development to accelerate the pipeline of innovative therapies.

Experience Summary

Current Roles

Chief Scientific Officer, Precede Biosciences (2024-01-01 to Present)

Provides strategic direction and technical oversight for the company's research and development efforts

Leads cross-functional teams in the advancement of novel cancer treatments and companion diagnostics

Collaborates with external partners and academic institutions to expand the company's scientific capabilities

Professor, University of North Carolina (2023-09-01 to Present)

Teaches graduate-level courses in cancer biology and translational medicine

Mentors and advises students on research projects and career development

Biotech Consultant, JCarl Consulting, LLC (2023-07-01 to Present)

Advises biotech and pharmaceutical companies on research strategies, clinical trial design, and regulatory considerations

Leverages extensive industry knowledge to help clients navigate complex scientific and operational challenges

Previous Roles

Vice President, Translational Medicine, Oncology, AstraZeneca (2011-03-01 to 2023-07-01)

Oversaw the development and implementation of translational research strategies for the company's oncology pipeline

Led cross-functional teams in the identification and validation of novel biomarkers to guide patient selection and therapeutic response

Vice President and Global Head, Biomarkers and Imaging, Novartis (2005-01-01 to 2011-01-01)

Spearheaded the company's efforts to integrate biomarker and imaging technologies into drug development programs

Drove the successful implementation of precision medicine approaches across multiple therapeutic areas

Director, Center for Cancer Research, National Cancer Institute (2000-01-01 to 2005-01-01)

Directed the research activities of a large, multidisciplinary team focused on advancing cancer treatments and diagnostic tools

Fostered collaborations with academic institutions and industry partners to accelerate the translation of scientific discoveries

Academic Background

Jcarl Barrett holds a Ph.D. in Molecular Biology from the Massachusetts Institute of Technology, where he specialized in cancer genomics and translational oncology. He has authored numerous peer-reviewed publications and holds several patents related to his pioneering work in the field of biomarker development and targeted cancer therapies.

Areas of Expertise

Oncology drug development and translational research

Biomarker discovery and validation

Precision medicine and companion diagnostics

Cross-functional team leadership and collaboration

Strategic planning and execution

Academic research and mentorship

Professional Impact

During his career, Jcarl Barrett has made significant contributions to the advancement of cancer research and the development of innovative therapeutic approaches. His work has had a measurable impact on the lives of patients, as evidenced by the successful commercialization of several targeted cancer therapies and companion diagnostics that were developed under his leadership.

Conclusion

With his unparalleled scientific expertise, proven track record of success, and strong commitment to advancing the field of oncology, Jcarl Barrett is poised to drive transformative change as the Chief Scientific Officer at Precede Biosciences. His multifaceted background and visionary approach position him as a highly valuable asset in the quest to develop groundbreaking cancer treatments and improve patient outcomes.